Meet Our Leaders

Adimab’s leadership and board combine scientific excellence, industry insight, and a proven track record of success, providing partners with trusted guidance and a strong foundation for advancing therapeutic discovery.

Philip Chase

Philip Chase

Chief Executive Officer

Eric Krauland, PhD

Eric Krauland, PhD

President and Chief Scientific Officer

Ryan McGovern

Ryan McGovern

Chief Financial Officer

Aaron Sato, PhD

Aaron Sato, PhD

Chief Strategy Officer

Guy Van Meter

Guy Van Meter

Chief Business Officer

Max Vásquez, PhD

Max Vásquez, PhD

Chief Computing Officer

Amy Bray, PhD

Amy Bray, PhD

Vice President, Legal

Robert Pejchal, PhD

Robert Pejchal, PhD

Vice President, Antibody Engineering

Kristin Rookey

Kristin Rookey

Vice President, Strategic Alliances

Katy Seneca

Katy Seneca

Vice President, Finance & Accounting

Tushar Jain, PhD

Tushar Jain, PhD

Senior Director, Computational Biology

Kirt Johnson

Kirt Johnson

Senior Director, Product Engineering & Operations

Juergen Nett, PhD

Juergen Nett, PhD

Senior Director, High-throughput Expression

William Roach, PhD

William Roach, PhD

Senior Director, Technology Alliances

Arvind Sivasubramanian, PhD

Arvind Sivasubramanian, PhD

Senior Director, Computational Biology & Platform Technologies

Paul Widboom, PhD

Paul Widboom, PhD

Senior Director, Technology

Let’s advance biologics together.

Learn how Adimab drives the discovery and development of antibody and other protein therapeutics.